M. Altaca Et Al. , "Interleukin-6, -17, and -35 levels in association with clinical status in stage III and stage IV periodontitis: a cross-sectional study," BMC Oral Health , vol.24, no.1, 2024
Altaca, M. Et Al. 2024. Interleukin-6, -17, and -35 levels in association with clinical status in stage III and stage IV periodontitis: a cross-sectional study. BMC Oral Health , vol.24, no.1 .
Altaca, M., Cebesoy, E. I., KOÇAK ÖZTUĞ, N. A., BİNGÜL, İ., & ÇİFCİBAŞI, E., (2024). Interleukin-6, -17, and -35 levels in association with clinical status in stage III and stage IV periodontitis: a cross-sectional study. BMC Oral Health , vol.24, no.1.
Altaca, Müge Et Al. "Interleukin-6, -17, and -35 levels in association with clinical status in stage III and stage IV periodontitis: a cross-sectional study," BMC Oral Health , vol.24, no.1, 2024
Altaca, Müge Et Al. "Interleukin-6, -17, and -35 levels in association with clinical status in stage III and stage IV periodontitis: a cross-sectional study." BMC Oral Health , vol.24, no.1, 2024
Altaca, M. Et Al. (2024) . "Interleukin-6, -17, and -35 levels in association with clinical status in stage III and stage IV periodontitis: a cross-sectional study." BMC Oral Health , vol.24, no.1.
@article{article, author={Müge Altaca Et Al. }, title={Interleukin-6, -17, and -35 levels in association with clinical status in stage III and stage IV periodontitis: a cross-sectional study}, journal={BMC Oral Health}, year=2024}